Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs MEDVidi

Eden
Site position #16

Higher grade

MEDVidi
Site position #433

Lower grade

The verdict

Eden takes it — 81.6/100 to 58/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEden +40
85
45
Dose & formulationEden +33
86
53
Clinical oversightMEDVidi +22
55
77
Labs & monitoringEden +30
92
62
FulfillmentEden +34
93
59
Contract termsEden +35
90
55
Eden · top barMEDVidi · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenMEDVidi
WeighScore81.6/10058/100
GradeB−C
Site position#16#433
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkoutNot disclosed
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkoutNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
MEDVidi

Site position #433 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

What to consider

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard